Form 4: Integrated Biopharma Director William Milmoe Exercises Stock Options, Increases Stake

Integrated Biopharma Inc. Director and 10% owner William H. Milmoe acquired 50,000 shares of common stock through the exercise of stock options at $0.09 per share, increasing his direct beneficial ownership to 138,667 shares.

Summary

• William H. Milmoe, a Director and 10% owner of Integrated Biopharma Inc. (INBP), acquired 50,000 shares of common stock.
• The acquisition occurred on May 30, 2025, through the exercise of a stock option grant.
• The exercise price for the shares was $0.09 per share.
• Following this transaction, Mr. Milmoe's direct beneficial ownership of common stock increased to 138,667 shares.
• The exercised options were part of a grant dated June 2, 2015, with 75% becoming exercisable immediately and the remaining 25% vesting in 12 equal monthly installments starting July 2, 2015.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director and 10% owner, leading to an increased stake, is generally viewed as a positive signal of confidence in the company's future prospects, although it's a routine compensation event.

Positives

• Insider acquisition of shares, which can signal confidence in the company's future prospects.
• The exercise price of $0.09 indicates the options were 'in the money' if the current market price is above this, suggesting a potential gain for the insider.

Risks

• While not detailed in the document, exercising options involves market risk if the stock price declines post-exercise.

Future Outlook

This Form 4 filing reports a past transaction and does not provide forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing pertains to an individual insider transaction and does not provide broader industry context or trends. It reflects an individual's decision regarding their equity compensation.

Related Party Transactions

• The transaction involves William H. Milmoe, a Director and 10% owner of Integrated Biopharma Inc., exercising stock options granted by the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may interpret the insider's increased stake as a positive sign of management's belief in the company's value and future performance.

Key Dates

Keywords

Integrated Biopharma Inc., INBP, SEC Form 4, Insider Trading, Stock Option Exercise, Beneficial Ownership, Director, 10% Owner, Equity Acquisition